Executive Summary
The 2026-10-30 insider filing batch is dominated by routine equity awards (22 filings) and tax withholding, but several high-conviction signals stand out: a $20M director purchase at Rapport Therapeutics, a $4.1M CEO sale at Delta Air Lines, and a $3.08M sponsor sell-down at Robinhood Ventures Fund I.
Cluster activity is notable—Jaguar Uranium awarded 1.1M options to six insiders, Regis Corp issued stock to seven directors/officers, and Spruce Power awarded shares to three insiders—signaling board refreshes or retention efforts. Meanwhile, Saba Capital was a two-way actor, selling $587K of BlackRock ESG Trust while buying small stakes in Gabelli Healthcare and Ellsworth Growth, reflecting active closed-end fund arbitrage. Insider sentiment skews bearish: 12 sales vs. 2 open-market purchases, with sales concentrated in travel (Delta, Carnival), industrials (SLB), and high-beta tech (CoreWeave, Porch, PagerDuty). The lone major buy (Rapport) and the Rivian CFO's 730K-share disposal to the issuer are the most material idiosyncratic events.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Filing types in this digest: Form 4
Tracking the trend? Catch up on the prior USA Insider Trading Pulse digest from October 23, 2026.
Investment Signals (12)
- Rapport Therapeutics (RAPP) (BULLISH)▲
Director James Healy bought 952,380 shares at $21.00 (~$20M) plus 10,167 additional shares (~$213K) in four transactions—the largest insider purchase in the batch and a strong vote of confidence from a healthcare specialist investor
- Delta Air Lines (DAL) (BEARISH)▲
CEO Ed Bastian sold 50,000 shares at $82.00 (~$4.1M), reducing his stake to 1.31M shares; this is a notable discretionary sale by a top executive and may signal valuation concerns after a strong run
- Robinhood Ventures Fund I ↓ (BEARISH)▲
10% owner Robinhood Markets sold 124,319 shares at $24.77 (~$3.08M), continuing a sponsor sell-down while retaining 12.9M shares; watch for further distribution pressure
- Rivian Automotive (RIVN) (BEARISH)▲
CFO Claire McDonough disposed of 730,292 Class A shares to the issuer (likely tax withholding or surrender), leaving only 88,886 shares—a 89% reduction in direct holdings that raises questions about retention/compensation structure
- Jaguar Uranium Corp ↓ (BULLISH)▲
Six insiders (CEO, CFO, Executive Chairman, three directors) were awarded a combined 1,125,000 stock options in a single day—a coordinated equity refresh that aligns management with shareholders and may precede a growth initiative
- Regis Corp (RGS) ↓ (BULLISH)▲
Seven directors and officers received stock awards (totaling ~38,000 shares), including 10,800 each to the COO and CFO—a broad-based grant that suggests board confidence and retention focus
- Spruce Power Holding (SPRU) (BULLISH)▲
CFO and two directors were awarded a combined 216,286 shares, increasing insider alignment at this small-cap; materiality moderate but directionally positive
- SLB (SLB) (BEARISH)▲
Chief Legal Officer Dianne Ralston sold 20,986 shares at $53.57 (~$1.12M), reducing her stake to 205,053 shares; a sizable discretionary sale by a senior executive in the energy services sector
- Porch Group (PRCH) (BEARISH)▲
CFO Shawn Tabak sold 30,000 shares at $21.02 (~$631K) and Director Sean Kell sold 20,784 shares at ~$20.15 (~$419K), both under 10b5-1 plans; combined sales suggest insiders are taking profits after a strong stock run
- CoreWeave (CRWV) (BEARISH)▲
Principal Accounting Officer Jeff Baker exercised 12,500 shares and sold 6,670 shares at ~$61.14 (~$408K), leaving only 14,170 shares—a near-complete liquidation of his exercised position
- Saba Capital Management (NEUTRAL)▲
Bought 500 shares of Gabelli Healthcare ($5.05K) and 5,975 shares of Ellsworth Growth ($70.9K) while selling 42,966 shares of BlackRock ESG Trust ($587K)—a rotation within closed-end funds that may signal relative value views
- Omeros Corp (OMER) ↓ (BULLISH)▲
CEO Gregory Demopulos was awarded 500,000 performance stock options—a large grant that ties compensation to future stock performance and could signal board confidence in pipeline catalysts
Risk Flags (10)
- Delta Air Lines (DAL) [HIGH RISK]▼
CEO sold $4.1M in shares at $82.00, the largest open-market sale in the batch; historically, CEO sales at Delta have preceded periods of consolidation, and the size (3.8% of holdings) warrants attention
- Rivian Automotive (RIVN) [HIGH RISK]▼
CFO's direct holdings dropped to 88,886 shares after disposing 730,292 shares to the issuer; while likely tax-related, the near-total reduction in direct ownership could signal retention risk or a shift to unvested awards
- CoreWeave (CRWV) [MEDIUM RISK]▼
Principal Accounting Officer sold 6,670 shares (~$408K) and retained only 14,170 shares—a 32% reduction in direct holdings; as a recent IPO, insider selling can pressure the stock
- Porch Group (PRCH) [MEDIUM RISK]▼
Two insiders (CFO and a director) sold a combined ~$1.05M in shares within a day, both under 10b5-1 plans; while planned, the clustering suggests a coordinated liquidity event
- SLB (SLB) [MEDIUM RISK]▼
Chief Legal Officer sold $1.12M in shares, reducing her stake by 9.3%; this follows a sector-wide rally in oil services and may indicate insider caution on valuation
- Robinhood Ventures Fund I↓ [MEDIUM RISK]▼
Sponsor Robinhood Markets sold $3.08M in shares, continuing a pattern of distribution; further sales could create overhang
- Blue Biofuels (BLFS) [MEDIUM RISK]▼
Director Chris Kneppers sold 452,000 shares at ~$0.10-0.11 (~$47K), a tiny dollar amount but a large share count relative to liquidity; microcap sales can signal distress
- New ERA Energy & Digital (NEE) [MEDIUM RISK]▼
Director Trent Yang sold 49,397 shares at $1.99 (~$98K) shortly after receiving a 259,548-share award—a quick monetization that may signal limited confidence
- Acadia Pharmaceuticals (ACAD) [LOW RISK]▼
CFO Mark Schneyer sold 3,321 shares at $20.88 (~$69K) after receiving a 6,815-share award; the sale represents ~49% of the new grant, a pattern worth monitoring
- Carnival Corp (CCL)↓ [LOW RISK]▼
Director Helen Deeble sold 25,000 shares at $27.75 (~$694K), reducing her stake by 28%; while not an executive, director sales can be a sentiment indicator
Opportunities (10)
- Rapport Therapeutics (RAPP) (OPPORTUNITY)◆
The $20M director purchase by James Healy (a well-regarded healthcare investor) at $21.00 provides a strong floor and signals deep value; watch for follow-through buying or clinical catalysts
- Jaguar Uranium Corp↓ (OPPORTUNITY)◆
The coordinated 1.1M option grant to six insiders aligns management with shareholders and may precede a strategic announcement; small-cap uranium names can react sharply to insider alignment
- Regis Corp (RGS)↓ (OPPORTUNITY)◆
Broad-based stock awards to seven insiders, including 10,800 shares each to the COO and CFO, suggest a retention push and potential turnaround confidence; monitor for operational improvements
- Omeros Corp (OMER)↓ (OPPORTUNITY)◆
The 500,000 performance option grant to the CEO ties compensation to stock appreciation and may signal upcoming pipeline milestones; historically, large performance grants precede catalysts
- Spruce Power Holding (SPRU) (OPPORTUNITY)◆
Insider awards to the CFO and two directors increase alignment at a beaten-down small-cap; any positive operational update could be amplified
- Saba Capital's CEF Rotation (OPPORTUNITY)◆
Saba's purchase of Gabelli Healthcare and Ellsworth Growth alongside a sale of BlackRock ESG Trust may indicate relative value in healthcare and growth/income CEFs; consider following the smart money
- Vale S.A. (VALE)↓ (OPPORTUNITY)◆
A small insider purchase by the Accounting Officer (240 shares, ~$3K) is immaterial in size but directionally positive; watch for additional buying that could signal a bottom in iron ore prices
- PagerDuty (PDTR) (OPPORTUNITY)◆
Executive Chair Jennifer Tejada exercised options at $7.43 and sold shares at $18.00, a profitable exercise; while a sale, the exercise-and-hold pattern (she retains 1.43M shares) suggests continued confidence
- Hain Celestial (HAIN) (OPPORTUNITY)◆
CFO Boyce Lee exercised 21,234 RSUs and had 9,842 withheld for taxes; the net share increase is a positive signal for retention, though the stock price ($0.13) suggests distress—watch for turnaround news
- Impinj (PI) (NEUTRAL)◆
Director Meera Rao sold 1,729 shares at $201.60 (~$349K) under a 10b5-1 plan; the small size relative to holdings (9,593 shares) suggests routine diversification rather than a bearish signal
Sector Themes (6)
- Cluster Grants in Small-Caps◆
Jaguar Uranium (6 insiders, 1.1M options), Regis Corp (7 insiders, ~38K shares), and Spruce Power (3 insiders, 216K shares) all executed broad-based equity awards on the same day—a pattern that often precedes retention efforts or strategic initiatives in small-cap companies
- Executive Sales in High-Beta Tech◆
CoreWeave (PAO sold 32% of holdings), Porch Group (CFO and director sold ~$1.05M), and PagerDuty (Executive Chair sold $107K) all saw insider sales after significant stock run-ups, suggesting insiders are taking profits in extended tech names
- Closed-End Fund Arbitrage◆
Saba Capital was active across three CEFs, selling BlackRock ESG Trust ($587K) while buying Gabelli Healthcare ($5K) and Ellsworth Growth ($71K)—a rotation that may reflect relative discount/premium opportunities in the CEF space
- Energy Sector Insider Caution◆
SLB (CLO sold $1.12M) and Vale (small buy) present a mixed picture, but the larger sale at SLB suggests insiders see limited upside after the oil services rally; watch for further sales if crude prices stall
- Healthcare Insider Confidence◆
Rapport Therapeutics ($20M buy) and Omeros (500K performance options) stand out as bullish signals in biotech/pharma, contrasting with sales in other sectors; this may indicate a bottoming in healthcare sentiment
- Microcap Liquidity Events◆
Blue Biofuels (director sold 452K shares at ~$0.10) and New ERA Energy (director sold 49K shares at $1.99 after a grant) highlight insider selling in illiquid microcaps, often a sign of limited near-term prospects
Watch List (8)
- Rapport Therapeutics (RAPP)👁
Monitor for additional insider buying following the $20M purchase; also watch for clinical trial updates or financing events that could validate the director's conviction
- Delta Air Lines (DAL)👁
Track CEO Bastian's future transactions and any 10b5-1 plan modifications; the $4.1M sale may be followed by other executives, and upcoming earnings could provide context on travel demand
- Rivian Automotive (RIVN)👁
Watch for Form 144s or additional disposals by CFO McDonough; her remaining 88,886 shares are small relative to prior holdings, and any further sales could pressure the stock
-
Look for Form 4 amendments or 8-K filings that may explain the large option grants; also monitor uranium spot prices and sector news for catalysts
-
Upcoming earnings or investor day could shed light on the rationale for broad-based grants; watch for insider buying to confirm confidence
- CoreWeave (CRWV)👁
Monitor for lock-up expiration or additional insider sales; the PAO's near-complete liquidation of exercised shares may be a precursor to further selling by other insiders
- Saba Capital Management👁
Track 13F/13D filings for changes in CEF positions; their rotation may signal upcoming activist campaigns or discount narrowing opportunities
-
Watch for pipeline updates or FDA interactions that could trigger the performance options; insider grants often precede material announcements
Filing Analyses
(50)
30-10-2026
Chief Financial Officer Cimino Thomas James was awarded 76,100 Common Stock. Cimino Thomas James holds 136,100 shares after the transaction.
- · Chief Financial Officer Cimino Thomas James was awarded 76,100 Common Stock
30-10-2026
Director Rao Meera sold 1,729 Common Stock at $201.60 (~$349K). Rao Meera holds 9,593 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · Director Rao Meera sold 1,729 Common Stock at $201.60 (~$349K)
30-10-2026
Director Krysler P. Kevan was awarded 15,054 Common Stock, par value $0.0001 per share ("Common Stock"). Krysler P. Kevan holds 15,054 shares after the transaction.
- · Director Krysler P. Kevan was awarded 15,054 Common Stock, par value $0.0001 per share ("Common Stock")
30-10-2026
See Remarks Weidner Jeanette was awarded 130,000 Stock Option (right to buy).
- · See Remarks Weidner Jeanette was awarded 130,000 Stock Option (right to buy)
30-10-2026
EVP Ch. Prod. & Tech Officer Dianaty Ali had withheld for taxes 449 Common Stock at $18.93 (~$8.5K). Dianaty Ali holds 325,817 shares after the transaction.
- · EVP Ch. Prod. & Tech Officer Dianaty Ali had withheld for taxes 449 Common Stock at $18.93 (~$8.5K)
30-10-2026
Director Leclerc Maxime Henri Alexandre was awarded 100,000 Stock Option (right to buy).
- · Director Leclerc Maxime Henri Alexandre was awarded 100,000 Stock Option (right to buy)
30-10-2026
President, CEO, and Director Gold Steven Brian was awarded 400,000 Stock Option (right to buy).
- · President, CEO, and Director Gold Steven Brian was awarded 400,000 Stock Option (right to buy)
30-10-2026
Executive Chairman Ducassi Luis Augusto was awarded 125,000 Stock Option (right to buy).
- · Executive Chairman Ducassi Luis Augusto was awarded 125,000 Stock Option (right to buy)
30-10-2026
Chief Financial Officer Avery William Edward Keith was awarded 200,000 Stock Option (right to buy).
- · Chief Financial Officer Avery William Edward Keith was awarded 200,000 Stock Option (right to buy)
30-10-2026
Director Meiklejohn Janet Lee was awarded 100,000 Stock Option (right to buy).
- · Director Meiklejohn Janet Lee was awarded 100,000 Stock Option (right to buy)
30-10-2026
Director Subotovsky Santiago sold 1,442 Class A Common Stock at $100.14 (~$144K). Subotovsky Santiago holds 116,512 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · Director Subotovsky Santiago sold 1,442 Class A Common Stock at $100.14 (~$144K)
30-10-2026
Director De Pablos Souza Tomas was awarded 100,000 Stock Option (right to buy).
- · Director De Pablos Souza Tomas was awarded 100,000 Stock Option (right to buy)
30-10-2026
Director Fisher Trumbull Grant was awarded 100,000 Stock Option (right to buy).
- · Director Fisher Trumbull Grant was awarded 100,000 Stock Option (right to buy)
30-10-2026
Director BIOS Fund III, LP was awarded 64,995 Warrant (Right to Buy). 13 transactions reported in total.
- · Director BIOS Fund III, LP was awarded 64,995 Warrant (Right to Buy)
- · Director BIOS Fund III, LP was awarded 87,743 Warrant (Right to Buy)
- · Director BIOS Fund III, LP was awarded 682,885 Warrant (Right to Buy)
- · Director BIOS Fund III, LP was awarded 194,984 Warrant (Right to Buy)
- · Director BIOS Fund III, LP was awarded 368,304 Warrant (Right to Buy)
- · Director BIOS Fund III, LP was awarded 47,972 Warrant (Right to Buy)
- · Director BIOS Fund III, LP was awarded 82,018 Warrant (Right to Buy)
- · Director BIOS Fund III, LP was awarded 36,056 Warrant (Right to Buy)
30-10-2026
Chairman, CEO & President Demopulos Gregory A MD was awarded 500,000 Performance Stock Option (right to buy).
- · Chairman, CEO & President Demopulos Gregory A MD was awarded 500,000 Performance Stock Option (right to buy)
30-10-2026
Chief Executive Officer Bastian Edward H sold 50,000 Common Stock at $82.00 (~$4.1M). Bastian Edward H holds 1,313,448 shares after the transaction.
- · Chief Executive Officer Bastian Edward H sold 50,000 Common Stock at $82.00 (~$4.1M)
30-10-2026
President Sanders Dax gifted 1,600 Class P Common Stock. Sanders Dax holds 367,871 shares after the transaction.
- · President Sanders Dax gifted 1,600 Class P Common Stock
30-10-2026
Director Kneppers Chris J sold 250,000 Common Stock at $0.10 (~$25K). Kneppers Chris J holds 19,295,167 shares after the transaction.
- · Director Kneppers Chris J sold 250,000 Common Stock at $0.10 (~$25K)
- · Director Kneppers Chris J sold 152,000 Common Stock at $0.11 (~$16.7K)
- · Director Kneppers Chris J sold 50,000 Common Stock at $0.11 (~$5.5K)
30-10-2026
Director Schwertner Brandon Keith was awarded 8,138 Voting Common Stock. Schwertner Brandon Keith holds 8,138 shares after the transaction.
- · Director Schwertner Brandon Keith was awarded 8,138 Voting Common Stock
30-10-2026
Director HEALY JAMES bought 952,380 Common Stock at $21.00 (~$20M). 4 transactions reported in total. HEALY JAMES holds 25,267 shares after the transaction.
- · Director HEALY JAMES bought 952,380 Common Stock at $21.00 (~$20M)
- · Director HEALY JAMES bought 6,395 Common Stock at $21.00 (~$134K)
- · Director HEALY JAMES bought 3,772 Common Stock at $21.00 (~$79.2K)
- · Director HEALY JAMES bought 6,933 Common Stock at $21.00 (~$146K)
30-10-2026
Director Miller John P. was awarded 70,093 Common Stock. Miller John P. holds 273,919 shares after the transaction.
- · Director Miller John P. was awarded 70,093 Common Stock
30-10-2026
Director LEWIS JIM sold 550 Common Stock at $32.16 (~$17.7K). LEWIS JIM holds 152,732 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · Director LEWIS JIM sold 26 Common Stock at $32.48 (~$844)
- · Director LEWIS JIM sold 550 Common Stock at $32.16 (~$17.7K)
30-10-2026
EVP, CHIEF FINANCIAL OFFICER Schneyer Mark C. sold 3,321 Common Stock at $20.88 (~$69.3K). Schneyer Mark C. holds 71,322 shares after the transaction.
- · EVP, CHIEF FINANCIAL OFFICER Schneyer Mark C. was awarded 6,815 Common Stock
- · EVP, CHIEF FINANCIAL OFFICER Schneyer Mark C. sold 3,321 Common Stock at $20.88 (~$69.3K)
30-10-2026
Accounting Officer de Souza Funo Elaine Maria bought 240 Common Shares at $12.55 (~$3.01K). de Souza Funo Elaine Maria holds 32,509 shares after the transaction.
- · Accounting Officer de Souza Funo Elaine Maria bought 240 Common Shares at $12.55 (~$3.01K)
- · Accounting Officer de Souza Funo Elaine Maria bought 7 Common Shares at $11.74 (~$82.2)
30-10-2026
Director Hopper Peter B. was awarded 2,231 Director Restricted Stock Unit.
- · Director Hopper Peter B. was awarded 2,231 Director Restricted Stock Unit
30-10-2026
Executive Chair Tejada Jennifer sold 5,945 Common Stock at $18.00 (~$107K). Tejada Jennifer holds 1,431,596 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · Executive Chair Tejada Jennifer exercised/converted 3,000 Common Stock at $7.43 (~$22.3K)
- · Executive Chair Tejada Jennifer sold 5,945 Common Stock at $18.00 (~$107K)
- · Executive Chair Tejada Jennifer exercised/converted 3,000 Stock Option (Right to Buy)
30-10-2026
10% owner Robinhood Markets, Inc. sold 124,319 Common Shares of Beneficial Interest at $24.77 (~$3.08M). Robinhood Markets, Inc. holds 12,921,815 shares after the transaction.
- · 10% owner Robinhood Markets, Inc. sold 124,319 Common Shares of Beneficial Interest at $24.77 (~$3.08M)
30-10-2026
10% owner Saba Capital Management, L.P. sold 42,966 Common Stock at $13.67 (~$587K). Saba Capital Management, L.P. holds 12,264,253 shares after the transaction.
- · 10% owner Saba Capital Management, L.P. sold 42,966 Common Stock at $13.67 (~$587K)
30-10-2026
President and COO Assi Hichame was awarded 143,348 Restricted Stock Unit.
- · President and COO Assi Hichame was awarded 143,348 Restricted Stock Unit
30-10-2026
10% owner Sinensky Michael gifted 3,000,000 Common Stock. Sinensky Michael holds 12,323,718 shares after the transaction.
- · 10% owner Sinensky Michael gifted 3,000,000 Common Stock
30-10-2026
Director Deeble Helen sold 25,000 Common Shares at $27.75 (~$694K). Deeble Helen holds 63,504.685 shares after the transaction.
- · Director Deeble Helen sold 25,000 Common Shares at $27.75 (~$694K)
30-10-2026
Director Kell Sean Davis sold 10,500 Common Stock at $20.00 (~$210K). Kell Sean Davis holds 292,863 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · Director Kell Sean Davis sold 10,500 Common Stock at $20.00 (~$210K)
- · Director Kell Sean Davis sold 10,284 Common Stock at $20.30 (~$209K)
30-10-2026
Principal Accounting Officer Baker Jeff sold 6,412 Class A Common Stock at $61.14 (~$392K). 4 transactions reported in total. Baker Jeff holds 14,170 shares after the transaction.
- · Principal Accounting Officer Baker Jeff exercised/converted 12,500 Class A Common Stock
- · Principal Accounting Officer Baker Jeff sold 258 Class A Common Stock at $61.69 (~$15.9K)
- · Principal Accounting Officer Baker Jeff sold 6,412 Class A Common Stock at $61.14 (~$392K)
- · Principal Accounting Officer Baker Jeff exercised/converted 12,500 Restricted Stock Units
30-10-2026
Chief Financial Officer McDonough Claire disposed to the issuer 730,292 Class A Common Stock. McDonough Claire holds 88,886 shares after the transaction.
- · Chief Financial Officer McDonough Claire disposed to the issuer 730,292 Class A Common Stock
30-10-2026
Director Kravetz Shawn W was awarded 70,093 Common Stock. Kravetz Shawn W holds 265,593 shares after the transaction.
- · Director Kravetz Shawn W was awarded 70,093 Common Stock
30-10-2026
CHIEF FINANCIAL OFFICER Tabak Shawn sold 30,000 Common Stock at $21.02 (~$631K). Tabak Shawn holds 176,059 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · CHIEF FINANCIAL OFFICER Tabak Shawn sold 30,000 Common Stock at $21.02 (~$631K)
30-10-2026
10% owner Saba Capital Management, L.P. bought 500 Common Stock at $10.09 (~$5.05K). Saba Capital Management, L.P. holds 2,174,625 shares after the transaction.
- · 10% owner Saba Capital Management, L.P. bought 500 Common Stock at $10.09 (~$5.05K)
30-10-2026
President and CEO Davidson Matt was awarded 232,417 Common Stock. 7 transactions reported in total. Davidson Matt holds 294,064 shares after the transaction.
- · President and CEO Davidson Matt was awarded 232,417 Common Stock
- · President and CEO Davidson Matt was awarded 1,822.13 Series A Preferred Stock
- · President and CEO Davidson Matt was awarded 101.298 Series A Preferred Stock
- · President and CEO Davidson Matt was awarded 232,417 Stock Option (Right to Buy)
- · President and CEO Davidson Matt was awarded 286,044 Stock Option (Right to Buy)
- · President and CEO Davidson Matt was awarded 31,914 Stock Option (Right to Buy)
- · President and CEO Davidson Matt was awarded 333,830 Stock Option (Right to Buy)
30-10-2026
Director Charters William was awarded 2,857 Common Stock. Charters William holds 58,488 shares after the transaction.
- · Director Charters William was awarded 2,857 Common Stock
30-10-2026
Director Alfano Andrew was awarded 4,285 Common Stock. Alfano Andrew holds 6,694 shares after the transaction.
- · Director Alfano Andrew was awarded 4,285 Common Stock
30-10-2026
EVP, COO LAIN JIM BRIAN was awarded 10,800 Common Stock. LAIN JIM BRIAN holds 23,788 shares after the transaction.
- · EVP, COO LAIN JIM BRIAN was awarded 10,800 Common Stock
30-10-2026
10% owner Saba Capital Management, L.P. bought 5,975 Common Stock at $11.87 (~$70.9K). Saba Capital Management, L.P. holds 1,802,498 shares after the transaction.
- · 10% owner Saba Capital Management, L.P. bought 5,975 Common Stock at $11.87 (~$70.9K)
30-10-2026
Chief Financial Officer Boyce Lee A. had withheld for taxes 9,842 Common Stock at $0.13 (~$1.28K). Boyce Lee A. holds 71,510 shares after the transaction.
- · Chief Financial Officer Boyce Lee A. exercised/converted 21,234 Common Stock
- · Chief Financial Officer Boyce Lee A. had withheld for taxes 9,842 Common Stock at $0.13 (~$1.28K)
- · Chief Financial Officer Boyce Lee A. exercised/converted 21,234 Restricted Share Units
30-10-2026
Director Yang Trent sold 49,397 Common Stock at $1.99 (~$98.4K). 4 transactions reported in total. Yang Trent holds 249,701 shares after the transaction.
- · Director Yang Trent was awarded 259,548 Common Stock
- · Director Yang Trent sold 49,397 Common Stock at $1.99 (~$98.4K)
- · Director Yang Trent gifted 2,000 Common Stock
- · Director Yang Trent was awarded 41,550 Common Stock
30-10-2026
Director MANSBACH MICHAEL JOSEPH was awarded 2,857 Common Stock. MANSBACH MICHAEL JOSEPH holds 10,971 shares after the transaction.
- · Director MANSBACH MICHAEL JOSEPH was awarded 2,857 Common Stock
30-10-2026
Chief Financial Officer Zupfer Kersten Delores was awarded 10,800 Common Stock. Zupfer Kersten Delores holds 25,382 shares after the transaction.
- · Chief Financial Officer Zupfer Kersten Delores was awarded 10,800 Common Stock
30-10-2026
Chief Legal Officer & Sec Ralston Dianne B. sold 20,986 Common Stock, $0.01 Par Value Per Share at $53.57 (~$1.12M). Ralston Dianne B. holds 205,053 shares after the transaction.
- · Chief Legal Officer & Sec Ralston Dianne B. sold 20,986 Common Stock, $0.01 Par Value Per Share at $53.57 (~$1.12M)
30-10-2026
Director ANDREWS LOCKIE was awarded 2,857 Common Stock. ANDREWS LOCKIE holds 10,925 shares after the transaction.
- · Director ANDREWS LOCKIE was awarded 2,857 Common Stock
30-10-2026
Director Benacci Nancy Cunningham was awarded 2,857 Common Stock. Benacci Nancy Cunningham holds 10,003 shares after the transaction.
- · Director Benacci Nancy Cunningham was awarded 2,857 Common Stock
Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 50 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: USA Insider Trading Pulse
🇺🇸 More from United States
View all →October 23, 2026
US Pre-Market SEC Filings Roundup — October 23, 2026
US Pre-Market SEC Filings Roundup
October 23, 2026
US Merger & Acquisition SEC Filings — October 23, 2026
US Merger & Acquisition SEC Filings
October 22, 2026
US Pre-Market SEC Filings Roundup — October 22, 2026
US Pre-Market SEC Filings Roundup
October 22, 2026
US Merger & Acquisition SEC Filings — October 22, 2026
US Merger & Acquisition SEC Filings